Benzinga's Top Analyst Calls From March 29, 2018

These headlines first appeared on Benzinga Pro.

  • Wedbush lowers GameStop Corp GME’s price target from $22.50 to $19, despite thinking shares are undervalued; Believes the company will continue to trade at a lower EPS multiple until it's able to slow the decline in its core video game business.
  • BMO increased DexCom Inc DXCM’s price target from $68 to $78 and reiterates Outperform rating as company received G6 CGM FDA approval ahead of schedule; Believes approval gives company momentum and awaits an update on product pricing, guidance on Q1 earnings call.
  • Deutsche Bank raises Nasdaq Inc NDAQ’s price target from $90 to $95 as they believe the company is poised to accelerate growth in tangent markets due to various tech capabilities; Believes company has an underappreciated growth story and is now attractively valued.
  • Bank Of America believes the government doesn't have an existing plan to target Amazon.Com, Inc. AMZN, which makes Thursday's sell-off an attractive buying opportunity assuming the sector stabilizes; Concludes it's hard to see a scenario that reduces the company's long-term value.
  • Jefferies would sell shares of L Brands Inc LB as many key product franchises are experiencing heavy promotion; firm says data indicates store traffic is weakening and that the Victoria Secret core business is eroding.
  • BMO raises Fortinet Inc FTNT’s price target from $50 to $58 based on improving operating margins, lower capex, and steady cash cycle days; Believes company can generate products growth in the low-single digits.
  • KeyBanc out defending Tesla Inc TSLA, says ongoing checks across the U.S. and conversations with Tesla lead the firm to believe the stock is likely oversold near term; Believes Model 3 volume is ramping and backlog is continuing to grow.
  • Credit Suisse downgrades Edge Therapeutics, Inc. EDGE from Outperform to Underperform and lowers price target from $7 to $1 as firm lowers EG-1962 probability of success from 55 percent to 0 percent after trial was discontinued; Firm notes company has no other products in development.

Related Links:

Benzinga's Top Upgrades, Downgrades For March 29, 2018

7 Biggest Price Target Changes For Thursday

Posted In: top analyst callsAnalyst ColorPrice TargetAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.